Literature DB >> 17362997

Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease.

Jon Infante1, Pascual Sánchez-Juan, Ignacio Mateo, Eloy Rodríguez-Rodríguez, Coro Sánchez-Quintana, Javier Llorca, Ana Fontalba, Jesús Terrazas, Agustín Oterino, José Berciano, Onofre Combarros.   

Abstract

Poly (ADP-ribose) polymerase-1 (PARP-1) is involved in crucial pathogenic events in Parkinson's disease (PD). We studied the effect of promoter variations of PARP-1 gene on the risk for PD in a case-control association study comprising 146 PD patients and 161 controls from Northern Spain. Three polymorphisms from the promoter region of PARP-1 gene were analyzed: -410C/T, -1672G/A, and a (CA)n microsatellite. A protective effect against PD was found for heterozygosity at (-410) (OR 0.44) and (CA)n microsatellite (OR 0.53) polymorphisms, and heterozygosity at (-1672) polymorphism delayed by 4 years on the onset age of PD. Variations in the regulatory region of PARP-1 gene might modify the risk for PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362997     DOI: 10.1016/j.jns.2007.02.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Evaluation of the poly(ADP-ribose) polymerase-1 gene variants in Alzheimer's disease.

Authors:  Hsin-Ping Liu; Wei-Yong Lin; Bor-Tsang Wu; Shu-Hsiang Liu; Wen-Fu Wang; Chon-Haw Tsai; Chun-Cheng Lee; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis.

Authors:  Maral Adel Fahmideh; Judith Schwartzbaum; Paolo Frumento; Maria Feychting
Journal:  Neuro Oncol       Date:  2014-02-04       Impact factor: 12.300

Review 3.  Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Authors:  Annadurai Anandhan; Maria S Jacome; Shulei Lei; Pablo Hernandez-Franco; Aglaia Pappa; Mihalis I Panayiotidis; Robert Powers; Rodrigo Franco
Journal:  Brain Res Bull       Date:  2017-03-21       Impact factor: 4.077

4.  Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling.

Authors:  Paola Castri; Yang-Ja Lee; Todd Ponzio; Dragan Maric; Maria Spatz; Joliet Bembry; John Hallenbeck
Journal:  Biochim Biophys Acta       Date:  2014-03

Review 5.  PARkinson's: From cellular mechanisms to potential therapeutics.

Authors:  Zsofia Lengyel-Zhand; Laura N Puentes; Robert H Mach
Journal:  Pharmacol Ther       Date:  2021-08-12       Impact factor: 12.310

6.  Influence of PARP-1 polymorphisms in patients after traumatic brain injury.

Authors:  Ajit A Sarnaik; Yvette P Conley; David O Okonkwo; Taura L Barr; Ericka L Fink; Csaba Szabo; Patrick M Kochanek; Robert S B Clark
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

Review 7.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 8.  An overview of DNA repair in amyotrophic lateral sclerosis.

Authors:  Fabio Coppedè
Journal:  ScientificWorldJournal       Date:  2011-10-17

9.  Association analysis of PARP1 polymorphisms with Parkinson's disease.

Authors:  Laura Brighina; Chiara Riva; Francesca Bertola; Silvia Fermi; Enrico Saracchi; Roberto Piolti; Stefano Goldwurm; Gianni Pezzoli; Carlo Ferrarese
Journal:  Parkinsonism Relat Disord       Date:  2011-07-20       Impact factor: 4.891

10.  Role of vitamin d in Parkinson's disease.

Authors:  Khanh L Ng; Lan Nguyễn
Journal:  ISRN Neurol       Date:  2012-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.